Skip to main content

Development of new multi-valent vaccine systems against Candida pathogens

Project description

A new vaccine against fungal pathogens

Treatment of fungal infections poses a significant medical challenge due to the few available drugs and the associated resistance. Efforts so far to develop vaccines have been met with limited success. VacCan is an EU-funded project that aims to develop a novel vaccine against Candida albicans, the leading cause of fungal infections in humans. Vaccine design will combine three proteins of the fungus, thereby providing multiple antigens against which a more robust immune response can be generated. The VacCan approach will advance vaccine research and pave the way for more effective management of fungal pathogens.

Coordinator

KING'S COLLEGE LONDON
Net EU contribution
€ 212 933,76
Address
Strand
WC2R 2LS London
United Kingdom

See on map

Region
London Inner London — West Westminster
Activity type
Higher or Secondary Education Establishments
Other funding
€ 212 933,76